Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Köhnke T[au]:

Recent developments in immunotherapy of acute myeloid leukemia. Lichtenegger FS et al. J Hematol Oncol. (2017)

Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200. Köhnke T et al. Br J Haematol. (2017)

Targeting CD157 in AML using a novel, Fc-engineered antibody construct. Krupka C et al. Oncotarget. (2017)

Search results

Items: 25

1.

Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia.

Lanvers-Kaminsky C, Niemann A, Eveslage M, Beck J, Köhnke T, Martin S, de Wit M, Spriewald B, Hauspurg H, Hoelzer D, Boos J, Gökbuget N.

Leuk Lymphoma. 2019 Sep 3:1-8. doi: 10.1080/10428194.2019.1658099. [Epub ahead of print]

PMID:
31480965
2.

A Role for Lipid Mediators in Acute Myeloid Leukemia.

Loew A, Köhnke T, Rehbeil E, Pietzner A, Weylandt KH.

Int J Mol Sci. 2019 May 16;20(10). pii: E2425. doi: 10.3390/ijms20102425. Review.

3.

Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction.

Köhnke T, Bücklein V, Rechkemmer S, Schneider S, Rothenberg-Thurley M, Metzeler KH, Sauerland MC, Hiddemann W, Spiekermann K, Subklewe M.

Haematologica. 2019 Apr 4. pii: haematol.2018.215236. doi: 10.3324/haematol.2018.215236. [Epub ahead of print]

4.

Data mining for mutation-specific targets in acute myeloid leukemia.

Benard B, Gentles AJ, Köhnke T, Majeti R, Thomas D.

Leukemia. 2019 Apr;33(4):826-843. doi: 10.1038/s41375-019-0387-y. Epub 2019 Feb 6. Review.

PMID:
30728456
5.

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML.

Haubner S, Perna F, Köhnke T, Schmidt C, Berman S, Augsberger C, Schnorfeil FM, Krupka C, Lichtenegger FS, Liu X, Kerbs P, Schneider S, Metzeler KH, Spiekermann K, Hiddemann W, Greif PA, Herold T, Sadelain M, Subklewe M.

Leukemia. 2019 Jan;33(1):64-74. doi: 10.1038/s41375-018-0180-3. Epub 2018 Jun 26.

6.

The high-intensity reflectometer of the Jülich Centre for Neutron Science: MARIA.

Mattauch S, Koutsioubas A, Rücker U, Korolkov D, Fracassi V, Daemen J, Schmitz R, Bussmann K, Suxdorf F, Wagener M, Kämmerling P, Kleines H, Fleischhauer-Fuß L, Bednareck M, Ossoviy V, Nebel A, Stronciwilk P, Staringer S, Gödel M, Richter A, Kusche H, Kohnke T, Ioffe A, Babcock E, Salhi Z, Bruckel T.

J Appl Crystallogr. 2018 May 29;51(Pt 3):646-654. doi: 10.1107/S1600576718006994. eCollection 2018 Jun 1.

7.

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Rothenberg-Thurley M, Amler S, Goerlich D, Köhnke T, Konstandin NP, Schneider S, Sauerland MC, Herold T, Hubmann M, Ksienzyk B, Zellmeier E, Bohlander SK, Subklewe M, Faldum A, Hiddemann W, Braess J, Spiekermann K, Metzeler KH.

Leukemia. 2018 Jul;32(7):1598-1608. doi: 10.1038/s41375-018-0034-z. Epub 2018 Feb 23.

8.

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Rothenberg-Thurley M, Amler S, Goerlich D, Köhnke T, Konstandin NP, Schneider S, Sauerland MC, Herold T, Hubmann M, Ksienzyk B, Zellmeier E, Bohlander SK, Subklewe M, Faldum A, Hiddemann W, Braess J, Spiekermann K, Metzeler KH.

Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.350. [Epub ahead of print]

PMID:
29249818
9.

Understanding the Inhibiting Effect of Small-Molecule Hydrogen Bond Donors on the Solubility of Cellulose in Tetrabutylammonium Acetate/DMSO.

Bengtsson J, Olsson C, Hedlund A, Köhnke T, Bialik E.

J Phys Chem B. 2017 Dec 21;121(50):11241-11248. doi: 10.1021/acs.jpcb.7b08501. Epub 2017 Dec 11.

10.

Wet Spinning of Flame-Retardant Cellulosic Fibers Supported by Interfacial Complexation of Cellulose Nanofibrils with Silica Nanoparticles.

Nechyporchuk O, Bordes R, Köhnke T.

ACS Appl Mater Interfaces. 2017 Nov 8;9(44):39069-39077. doi: 10.1021/acsami.7b13466. Epub 2017 Oct 20.

PMID:
29028306
11.

Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.

Köhnke T, Wittmann VK, Bücklein VL, Lichtenegger F, Pasalic Z, Hiddemann W, Spiekermann K, Subklewe M.

Br J Haematol. 2017 Nov;179(3):480-487. doi: 10.1111/bjh.14901. Epub 2017 Aug 18.

PMID:
28832948
12.

Recent developments in immunotherapy of acute myeloid leukemia.

Lichtenegger FS, Krupka C, Haubner S, Köhnke T, Subklewe M.

J Hematol Oncol. 2017 Jul 25;10(1):142. doi: 10.1186/s13045-017-0505-0. Review.

13.

Targeting CD157 in AML using a novel, Fc-engineered antibody construct.

Krupka C, Lichtenegger FS, Köhnke T, Bögeholz J, Bücklein V, Roiss M, Altmann T, Do TU, Dusek R, Wilson K, Bisht A, Terrett J, Aud D, Pombo-Villar E, Rohlff C, Hiddemann W, Subklewe M.

Oncotarget. 2017 May 30;8(22):35707-35717. doi: 10.18632/oncotarget.16060.

14.

Studying Soft-matter and Biological Systems over a Wide Length-scale from Nanometer and Micrometer Sizes at the Small-angle Neutron Diffractometer KWS-2.

Radulescu A, Szekely NK, Appavou MS, Pipich V, Kohnke T, Ossovyi V, Staringer S, Schneider GJ, Amann M, Zhang-Haagen B, Brandl G, Drochner M, Engels R, Hanslik R, Kemmerling G.

J Vis Exp. 2016 Dec 8;(118). doi: 10.3791/54639.

15.

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab.

Köhnke T, Krupka C, Tischer J, Knösel T, Subklewe M.

J Hematol Oncol. 2015 Oct 8;8:111. doi: 10.1186/s13045-015-0213-6.

16.

Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism.

Krupka C, Kufer P, Kischel R, Zugmaier G, Lichtenegger FS, Köhnke T, Vick B, Jeremias I, Metzeler KH, Altmann T, Schneider S, Fiegl M, Spiekermann K, Bauerle PA, Hiddemann W, Riethmüller G, Subklewe M.

Leukemia. 2016 Feb;30(2):484-91. doi: 10.1038/leu.2015.214. Epub 2015 Aug 4.

PMID:
26239198
17.

Immunotherapy for Acute Myeloid Leukemia.

Lichtenegger FS, Krupka C, Köhnke T, Subklewe M.

Semin Hematol. 2015 Jul;52(3):207-14. doi: 10.1053/j.seminhematol.2015.03.006. Epub 2015 Mar 17. Review.

PMID:
26111468
18.

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings.

Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, Zoellner AK, Bücklein V, Reibke R, Mumm F, Rieger CT, Hill W, Ledderose G, Stemmler HJ, Köhnke T, Jäger G, Kolb HJ, Schmid C, Moosmann A, Hausmann A.

Ann Hematol. 2015 Oct;94(10):1677-88. doi: 10.1007/s00277-015-2423-y. Epub 2015 Jun 10.

PMID:
26055139
19.

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse.

Köhnke T, Sauter D, Ringel K, Hoster E, Laubender RP, Hubmann M, Bohlander SK, Kakadia PM, Schneider S, Dufour A, Sauerland MC, Berdel WE, Büchner T, Wörmann B, Braess J, Hiddemann W, Spiekermann K, Subklewe M.

Leukemia. 2015 Feb;29(2):377-86. doi: 10.1038/leu.2014.186. Epub 2014 Jun 10.

PMID:
24912430
20.

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.

Hubmann M, Köhnke T, Hoster E, Schneider S, Dufour A, Zellmeier E, Fiegl M, Braess J, Bohlander SK, Subklewe M, Sauerland MC, Berdel WE, Büchner T, Wörmann B, Hiddemann W, Spiekermann K.

Haematologica. 2014 Aug;99(8):1317-25. doi: 10.3324/haematol.2014.104133. Epub 2014 May 9.

21.

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330.

Krupka C, Kufer P, Kischel R, Zugmaier G, Bögeholz J, Köhnke T, Lichtenegger FS, Schneider S, Metzeler KH, Fiegl M, Spiekermann K, Baeuerle PA, Hiddemann W, Riethmüller G, Subklewe M.

Blood. 2014 Jan 16;123(3):356-65. doi: 10.1182/blood-2013-08-523548. Epub 2013 Dec 3.

22.

Ice templated and cross-linked xylan/nanocrystalline cellulose hydrogels.

Köhnke T, Elder T, Theliander H, Ragauskas AJ.

Carbohydr Polym. 2014 Jan 16;100:24-30. doi: 10.1016/j.carbpol.2013.03.060. Epub 2013 Mar 26.

PMID:
24188834
23.

Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators.

Köhnke T, Gomolka B, Bilal S, Zhou X, Sun Y, Rothe M, Baumgart DC, Weylandt KH.

Biomed Res Int. 2013;2013:748160. doi: 10.1155/2013/748160. Epub 2013 Sep 8.

24.

Adsorption of arabinoxylan on cellulosic surfaces: influence of degree of substitution and substitution pattern on adsorption characteristics.

Köhnke T, Ostlund A, Brelid H.

Biomacromolecules. 2011 Jul 11;12(7):2633-41. doi: 10.1021/bm200437m. Epub 2011 Jun 7.

PMID:
21598942
25.

Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis.

Weylandt KH, Nadolny A, Kahlke L, Köhnke T, Schmöcker C, Wang J, Lauwers GY, Glickman JN, Kang JX.

Biochim Biophys Acta. 2008 Nov;1782(11):634-41. doi: 10.1016/j.bbadis.2008.08.011. Epub 2008 Sep 12.

Supplemental Content

Loading ...
Support Center